Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00212641
Other study ID # ONO-5129POU006
Secondary ID
Status Completed
Phase Phase 2
First received September 12, 2005
Last updated October 10, 2012
Start date June 2005

Study information

Verified date October 2012
Source Ono Pharmaceutical Co. Ltd
Contact n/a
Is FDA regulated No
Health authority United States: Food and Drug Administration
Study type Interventional

Clinical Trial Summary

The objectives of this study are to characterize the pharmacodynamic profile, safety and tolerability of ONO-5129 in patients with Type 2 Diabetes mellitus


Recruitment information / eligibility

Status Completed
Enrollment 105
Est. completion date
Est. primary completion date October 2007
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria:

1. Type 2 Diabetes Mellitus

2. FBG level > 140 mg/dL and < 270 mg/dL

3. Fasting TG level < 500 mg/dL

4. BMI of 22 to 40 kg/m2, inclusive

5. Other Inclusion criteria as specified in the study protocol

Exclusion Criteria:

1. Previous participation in an ONO-5129 protocol

2. Previous treatment with TZD agents or other current antidiabetics

3. History of myocardial infarction, coronary artery surgery, atrial/ventricular tachycardia, or atrial/ventricular fibrillation in the past six months

4. Presence of functional limitations due to cardiovascular disease in accordance with the New York Heart Association Classification System - Class III (moderate) or IV (severe)

5. Other exclusion criteria as specified in the study protocol

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Drug:
ONO-5129


Locations

Country Name City State
United States Keystone Clinical Solutions Altoona Pennsylvania
United States Executive Health and Research Associates, Inc. Atlanta Georgia
United States Sagebrush Medical Plaza, Department of Family Medicine Bakersfield California
United States Franklin Square Hospital Center Baltimore Maryland
United States Acadia Clinical Research, LLC Bangor Maine
United States Dolby Research, LLC Baton Rouge Louisiana
United States Apex Clinical Trials, Inc. Birmingham Alabama
United States Greystone Medical Research, LLC Birmingham Alabama
United States Capital City Family Medicine Boise Idaho
United States Orthopedic Health Care Clinic Boise Idaho
United States Sonora Clinical Research Boise Idaho
United States Mercury Street Medical Butte Montana
United States Professional Clinical Reserach -Great Lakes Family Care Cadillac Michigan
United States Med Search, LLC Calera Alabama
United States John Joseph, MD PA Carrollton Texas
United States Hyperion Clinical Trials, Inc. Charleston West Virginia
United States Cedar-Crosse Research Center Chicago Illinois
United States Chicago Research Center, Inc. Chicago Illinois
United States New Horizons Clinical Research Cincinnati Ohio
United States Alliance Medical Reserach Group, Inc. Clearwater Florida
United States Bassett Healthcare Cooperstown New York
United States Renaissance Clinical Research Dallas Texas
United States Personal Physician Care Delray Beach Florida
United States Centennial Medical Group Elkridge Maryland
United States Family Medical Center Foothill Ranch California
United States DiGiovanna Family Care Center Great Neck New York
United States United Physicians Group - Endocrine Division Great Neck New York
United States Southeastern PA Medical Institute Havertown Pennsylvania
United States Century Clinical Research, Inc Holly Hill Florida
United States MCA Research Houston Texas
United States Southwest Houston Research, LTD Houston Texas
United States Medical Affiliated Research Center Huntsville Alabama
United States Wells Institute for Health Awareness Kettering Ohio
United States Greenand Seidner Family Practice Lansdale Pennsylvania
United States Innovative Research of West Florida Largo Florida
United States Arapahoe Internal Medicine Littleton Colorado
United States Fallen Timbers Internal Medicine LLC Maumee Ohio
United States Cllinical Research Consultants Medford Oregon
United States Clinic of Physicians and Surgeons Mesa Arizona
United States Horizon Clinical Research Associates Mesa Arizona
United States Winthrop University Hospital Mineola New York
United States Prime-Care Clinical Research Mission Viejo California
United States Institute Diabetes and Metabolic Disease Newark Delaware
United States COR Clinical Reserch, LLC Oklahoma City Oklahoma
United States Specialty Medical Center Pahrump Nevada
United States Founders Medical Practice Philadelphia Pennsylvania
United States Thomas Jefferson University Div of Endocrinology Philadelphia Pennsylvania
United States Research Endeavors Pittsburg Pennsylvania
United States Professional for Clinical Research Plano Texas
United States Research Across America Plano Texas
United States Covance Clinical Research Unit, Inc Portland Oregon
United States Michael A. Azorr, M.D. Portland Oregon
United States Synergy Medical Education Alliance Saginaw Michigan
United States Medex Healthcare Research, Inc Saint Louis Missouri
United States Benjamin Garwood Research San Antonio Texas
United States Diabetes and Glandular Disease - Westside office San Antonio Texas
United States Diabetes and Glandular Disease Research Associates San Antonio Texas
United States WellMed at Northern Hills San Antonio Texas
United States Cardiovascular Center of Sarasota Sarasota Florida
United States Heart of America Research Shawnee Kansas
United States Cochise Clinical Research Sierra Vista Arizona
United States Hillcrest Clinical Research LLC Simpsonville South Carolina
United States Spartanburg Medical Research Spartanburg South Carolina
United States Encompass Clinical Research Spring Valley California
United States Liberty Research Center Tacoma Washington
United States Orange County Research Center Tustin California
United States Quality Care Medical Center Vista California

Sponsors (1)

Lead Sponsor Collaborator
Ono Pharma USA Inc

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Fasting Blood Glucose at 8 weeks
Secondary Pharmacodynamic parameters at all time points
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05666479 - CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery
Completed NCT05647083 - The Effect of Massage on Diabetic Parameters N/A
Active, not recruiting NCT05661799 - Persistence of Physical Activity in People With Type 2 Diabetes Over Time. N/A
Completed NCT03686722 - Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetis and Pharmacodynamics of Metformin Phase 1
Completed NCT02836704 - Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose) Phase 4
Completed NCT01819129 - Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes Phase 3
Completed NCT04562714 - Impact of Flash Glucose Monitoring in People With Type 2 Diabetes Using Non-Insulin Antihyperglycemic Therapy N/A
Completed NCT02009488 - Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM) Phase 1
Completed NCT05896319 - Hyaluronic Acid Treatment of the Post-extraction Tooth Socket Healing in Subjects With Diabetes Mellitus Type 2 N/A
Recruiting NCT05598203 - Effect of Nutrition Education Groups in the Treatment of Patients With Type 2 Diabetes N/A
Completed NCT05046873 - A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy People Phase 1
Completed NCT04030091 - Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus Phase 4
Terminated NCT04090242 - Impact of App Based Diabetes Training Program in Conjunction With the BD Nano Pen Needle in People With T2 Diabetes N/A
Completed NCT03604224 - A Study to Observe Clinical Effectiveness of Canagliflozin 300 mg Containing Treatment Regimens in Indian Type 2 Diabetes Participants With BMI>25 kg/m^2, in Real World Clinical Setting
Completed NCT03620357 - Continuous Glucose Monitoring & Management In Type 2 Diabetes (T2D) N/A
Completed NCT01696266 - An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
Completed NCT03620890 - Detemir Versus NPH for Type 2 Diabetes Mellitus in Pregnancy Phase 4
Withdrawn NCT05473286 - A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice
Not yet recruiting NCT05029804 - Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes N/A
Completed NCT04531631 - Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in T2D and Monogenic Diabetes Phase 2